Insider Selling: PTC Therapeutics (NASDAQ:PTCT) EVP Sells 829 Shares of Stock

robot
Abstract generation in progress

PTC Therapeutics (NASDAQ:PTCT) EVP Lee Scott Golden sold 829 shares of the company’s stock on April 2nd for $67.99 per share, totaling $56,363.71. This sale, conducted under a Rule 10b5-1 plan to cover tax withholdings, decreased his holdings by 1.04% to 79,115 shares valued at approximately $5.38 million. This transaction is part of a series of insider sales by Golden this year, occurring alongside the company’s recent earnings miss and a “Moderate Buy” average analyst rating with an $82.71 price target.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin